Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
ITGR 
Integer Holdings Corp (ITGR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: ITGR (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $140.88
1 Year Target Price $140.88
| 7 | Strong Buy |
| 2 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 23.8% | Avg. Invested days 76 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 09/16/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.51B USD | Price to earnings Ratio 42.82 | 1Y Target Price 140.88 |
Price to earnings Ratio 42.82 | 1Y Target Price 140.88 | ||
Volume (30-day avg) 10 | Beta 1.03 | 52 Weeks Range 99.73 - 146.36 | Updated Date 09/16/2025 |
52 Weeks Range 99.73 - 146.36 | Updated Date 09/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.34 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 4.61% | Operating Margin (TTM) 13.42% |
Management Effectiveness
Return on Assets (TTM) 4.6% | Return on Equity (TTM) 5.15% |
Valuation
Trailing PE 42.82 | Forward PE 16.29 | Enterprise Value 4848403354 | Price to Sales(TTM) 1.96 |
Enterprise Value 4848403354 | Price to Sales(TTM) 1.96 | ||
Enterprise Value to Revenue 2.7 | Enterprise Value to EBITDA 17.22 | Shares Outstanding 35034800 | Shares Floating 34635770 |
Shares Outstanding 35034800 | Shares Floating 34635770 | ||
Percent Insiders 1.19 | Percent Institutions 116.14 |
Upturn AI SWOT
Integer Holdings Corp
Company Overview
History and Background
Integer Holdings Corp. was founded in 1934 as Greatbatch, Inc., initially focused on battery technology. Over time, it evolved into a medical device outsource manufacturer, expanding its capabilities through strategic acquisitions and organic growth. The company rebranded as Integer Holdings Corp. in 2016 to reflect its broader focus and capabilities.
Core Business Areas
- Medical: This segment develops and manufactures medical devices and components for cardiovascular, neuromodulation, orthopedics, and other therapeutic areas. It includes products like leads, delivery systems, and complex surgical tools.
- Cardio & Vascular: Focuses on cardiac rhythm management, electrophysiology, vascular, and structural heart markets. Products include pacing leads, guidewires, and delivery systems.
- Advanced Surgical: Provides high-precision components, minimally invasive surgical tools, and instruments.
- Power Solutions: Designs and manufactures batteries and energy storage solutions for medical, industrial, and military applications.
Leadership and Structure
Integer Holdings Corp. is led by a CEO and a senior management team responsible for overseeing the company's operations and strategy. The organizational structure typically includes functional departments such as finance, operations, sales, and marketing.
Top Products and Market Share
Key Offerings
- Cardiac Rhythm Management (CRM) Leads: Integer is a major supplier of CRM leads, including pacing and defibrillation leads. Their market share is significant, though specific figures fluctuate. Competitors include Medtronic (MDT), Abbott (ABT), and Boston Scientific (BSX). Integer produces a wide range of specialized medical device leads with advanced components, which they design and manufacture for their customers.
- Advanced Surgical Tools and Components: They manufacture minimally invasive surgical tools, components, and instruments. Revenue varies depending on customer demand and project timelines, but is a substantial portion of overall revenue. Competitors include Te Connectivity (TEL), Stryker (SYK), and Smith & Nephew (SNN).
- Medical Batteries: Integer designs and manufactures batteries and energy storage solutions for implantable medical devices. Competitors include EaglePicher Technologies and Saft. Number of units vary greatly. Market share for these products depends on the specific battery types. Integer produces a wide range of energy storage solutions.
Market Dynamics
Industry Overview
The medical device outsourcing industry is experiencing growth, driven by increasing demand for medical devices, cost pressures on device manufacturers, and technological advancements.
Positioning
Integer Holdings Corp. is positioned as a leading medical device outsource manufacturer, with a focus on innovation, quality, and customer service. They serve major medical device OEMs and offer vertically integrated solutions.
Total Addressable Market (TAM)
The global medical device outsourcing market is projected to reach hundreds of billions of USD. Integer's positioning as a key supplier allows it to capture a significant portion of this market. Integer services multiple markets.
Upturn SWOT Analysis
Strengths
- Strong market position as a leading medical device outsource manufacturer
- Broad portfolio of products and services
- Vertically integrated capabilities
- Long-standing relationships with major medical device OEMs
- Focus on innovation and quality
Weaknesses
- Customer concentration
- Exposure to regulatory changes
- Dependence on key suppliers
- Competition from other outsource manufacturers
- Vulnerability to economic downturns
Opportunities
- Growth in emerging markets
- Increasing demand for minimally invasive procedures
- Technological advancements in medical devices
- Expansion of product offerings
- Strategic acquisitions
Threats
- Intensifying competition
- Pricing pressure from customers
- Product liability claims
- Economic uncertainty
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- Medtronic (MDT)
- TE Connectivity (TEL)
- Boston Scientific (BSX)
- Abbott (ABT)
Competitive Landscape
Integer competes on factors such as price, quality, innovation, and customer service. Their vertically integrated capabilities and strong relationships with OEMs provide a competitive advantage.
Major Acquisitions
Oscor Medical
- Year: 2020
- Acquisition Price (USD millions): 220
- Strategic Rationale: Expanded Integer's CRM and neuromodulation capabilities.
Growth Trajectory and Initiatives
Historical Growth: Integer has experienced consistent growth over the past few years, driven by increasing demand for medical devices and outsourcing services.
Future Projections: Analysts anticipate continued growth for Integer, supported by favorable industry trends and strategic initiatives.
Recent Initiatives: Recent strategic initiatives include acquisitions to expand capabilities and market reach, investments in research and development, and operational improvements to enhance efficiency.
Summary
Integer Holdings Corp. is a strong player in the medical device outsourcing market, driven by its comprehensive services and long-standing relationships. Increasing revenues and strategic acquisitions highlight their commitment to growth. However, competition and customer concentration require ongoing vigilance. Integer's focus on innovation and quality positions them well for future success within the industry.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Integer Holdings Corp. Investor Relations
- SEC Filings (10-K, 10-Q)
- Industry Reports
- Analyst Estimates
Disclaimers:
This analysis is based on publicly available information and analyst estimates. Actual results may vary. This is not financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Integer Holdings Corp
Exchange NYSE | Headquaters Plano, TX, United States | ||
IPO Launch date 2000-09-29 | President, CEO & Director Mr. Joseph W. Dziedzic | ||
Sector Healthcare | Industry Medical Devices | Full time employees 11000 | Website https://www.integer.net |
Full time employees 11000 | Website https://www.integer.net | ||
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. The company was founded in 1970 and is headquartered in Plano, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.